CLINICAL TRIAL SUMMARY

MDACC Study No:2009-0591 (clinicaltrials.gov NCT No: NCT01259284)
Title:A Double Blinded, Randomized Study Comparing the Effectiveness of Fish Oil Supplements, Oral Statins, and Placebo in Reducing the Incidence of Atrial Fibrillation Following a Lung Resection
Principal Investigator:Ara Vaporciyan
Treatment Agent:Atorvastatin; Fish Oil; Placebo
Study Status:Terminated
Study Description:This goal of this clinical research study is to learn if Lipitor (atorvastatin)
or fish oil supplements can help to control side effects of the heart that are
commonly seen after lung surgery (such as irregular heartbeat). Researchers
also want to learn if one of these drugs is more effective than the other at
controlling side effects.

Hide details for General InformationGeneral Information

Disease Group:Advanced Cancers; Breast; Colorectum; Genitourinary; Head And Neck; Lung; Melanoma; Sarcoma
Phase of Study:Phase II/Phase III
Treatment Agents:Atorvastatin
Fish Oil
Placebo
Treatment Location:Only at MDACC
Estimated Length of Stay in Houston:6 days following surgery
Supported By:N/A
Return Visit:At least one visit within 6 weeks of surgery
Home Care:Not part of this study


Hide details for Study Contact InformationStudy Contact Information

Physician Name:Ara Vaporciyan
Dept:Thoracic & Cardiovascular
For Clinical Trial Enrollment:713-745-4530
For General Questions about Clinical Trials:800-392-1611 (in U.S.A.) 713-792-6161 (outside U.S.A.)


Show details for Study Objectives / OutcomesStudy Objectives / Outcomes
Show details for Study Status InformationStudy Status Information
Show details for Enrollment EligibilityEnrollment Eligibility
Show details for Resources and LinksResources and Links
Show details for ResultsResults